ResMed (RMD) PT Raised to $304 at Morgan Stanley
Tweet Send to a Friend
Morgan Stanley analyst David Bailey raised the price target on ResMed (NYSE: RMD) to $304.00 (from $298.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
